DermACELL®

Acellular dermal matrix

Dermacell is a decellularized regenerative human tissue matrix allograft processed using proprietary MATRACELL® technology from LifeNet Health.

  

LifeNet Health has over 30 years of experience in tissue processing and holds the longest-running accreditation with the American Association of Tissue Banks (AATB).1

Related categories


DermACELL is
sterile and ≥97% donor DNA free

 

Sterility assurance level (SAL) 10-6 and ready to use - no rinsing required.

 

Dermacell is decellularized using Matracell, a proprietary and patented technology that removes at least 97% of donor DNA without compromising the desired biomechanical structure or biochemical properties for its intended use.2

After being rendered acellular, Dermacell undergoes a terminal sterilization step to ensure a Sterility Assurance Level (SAL) of 10-6.

Low-dose gamma irradiation performed at ultra-low temperatures is used to reach surgical device-grade sterility, which lowers the probability of an active organism in the graft to 1 in 1,000,000.2


DermACELL Acellular Dermal Matrix

Sterile

Sterility assurance level (SAL) 10-6.2

 

Ready to use (RTU)

No rinsing required.2

 

≥97% Donor DNA-Free

A proprietary and patented technology that removes at least 97% of donor DNA without compromising the desired biomechanical structure or biochemical properties for its intended use.2

 

Operative benefits

Dermacell provides a medical device-grade sterility assurance level of 10-6 and requires no rinsing prior to application.2 The graft features a wide suture border to further support intraoperative placement.


Connect with us

Have feedback about Stryker’s products and services? Visit our product experience page to connect with us. 

Visiting from outside the United States? Visit our country index to learn more about what's available in your country. 

Thank you! We have received your request. A Stryker representative will be in contact with you soon.